<DOC>
	<DOCNO>NCT02253407</DOCNO>
	<brief_summary>This study plan determine compare immunogenicity reactogenicity MMR vaccine SIIL deliver either disposable-Syringe Jet Injector ( DSJI ) disposable-syringe needle total 340 Indian infant age 15 18 month .</brief_summary>
	<brief_title>Safety &amp; Immunogenicity MMR Vaccine DSJI That Needle-Syringe 15-18 Months Old Children</brief_title>
	<detailed_description>This randomize , observer blind , non-inferior , parallel group , multi-centre clinical study determine compare immunogenicity reactogenicity MMR vaccine SIIL deliver either disposable-Syringe Jet Injector ( DSJI ) disposable-syringe needle total 340 Indian infant age 15 18 month . Sera sample analyze ELISA seroconversion / seropositivity individual component vaccine i.e . measles , mumps rubella 35 day administration single dose MMR vaccine Serum Institute India .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Normal healthy infant age 1518 month time screen receive first dose MMR vaccine . 2 . Previously receive measles monovalent vaccine 9 month , confirm childhood vaccination record . 3 . Parents legal guardian subject willing give write informed consent willing comply study protocol . 4 . Free obvious health problem establish medical history screen evaluation include clinical examination . 1 . Infant subject participate clinical trial plan participation another clinical trial present trial period 2 . Infant congenital acquire immunodeficiency , malignancy receive immunosuppressive therapy . 3 . Infant history allergy systemic hypersensitivity vaccine component vaccine contain substance . 4 . Infant history epilepsy seizure disorder neurodevelopmental disorder . 5 . Clinical history measles , mumps , rubella infection . 6 . Infants leukemia , lymphoma , cancer neoplasm . 7 . Acute chronic , clinically significant pulmonary , endocrine , autoimmune , neurological , cardiovascular , metabolic , hepatic renal functional abnormality , determine medical history , physical examination test , opinion investigator , might interfere study objective 8 . Infant condition , , opinion investigator would jeopardize safety right infant participate study make unlikely subject could complete protocol .</criteria>
	<gender>All</gender>
	<minimum_age>15 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>